Article Details
Retrieved on: 2024-01-15 13:51:23
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the growth of the global aptamers market, emphasizing its application in chronic disease treatment via biotechnology advancements like nucleic acid and peptide aptamers. It highlights the SELEX process and collaborations by companies like AstraZeneca and Aptamer Group plc to innovate biotechnology solutions, including optimer ligands and biosensors, for preventive healthcare.
Article found on: www.businessupturn.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here